UA110609C2 - Compounds for inhibition of the enzyme proteasome - Google Patents

Compounds for inhibition of the enzyme proteasome

Info

Publication number
UA110609C2
UA110609C2 UAA201209116A UAA201209116A UA110609C2 UA 110609 C2 UA110609 C2 UA 110609C2 UA A201209116 A UAA201209116 A UA A201209116A UA A201209116 A UAA201209116 A UA A201209116A UA 110609 C2 UA110609 C2 UA 110609C2
Authority
UA
Ukraine
Prior art keywords
present
proteasome
inhibition
enzyme
compounds
Prior art date
Application number
UAA201209116A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Кевін Д. Шенк
Франческо Парлаті
Хан-джаі Жоу
Катрін Сільван
Марк С. Сміт
Марк К. Беннетт
Гай Дж. Лайдіг
Original Assignee
Онікс Терап'Ютікс, Інк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Онікс Терап'Ютікс, Інк. filed Critical Онікс Терап'Ютікс, Інк.
Publication of UA110609C2 publication Critical patent/UA110609C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

One aspect of the invention relates to inhibitors which inhibit the activity mainly imunoproteasomy relatively constitutive proteasome activity. In certain embodiments, the present invention relates to the treatment of immune-related diseases, comprising administering a compound of the present invention. In certain embodiments, the present invention relates to the treatment of cancer, comprising administering a compound of the present invention.
UAA201209116A 2007-06-19 2007-06-19 Compounds for inhibition of the enzyme proteasome UA110609C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA200814605 2007-06-19

Publications (1)

Publication Number Publication Date
UA110609C2 true UA110609C2 (en) 2016-01-25

Family

ID=55701311

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201209116A UA110609C2 (en) 2007-06-19 2007-06-19 Compounds for inhibition of the enzyme proteasome

Country Status (1)

Country Link
UA (1) UA110609C2 (en)

Similar Documents

Publication Publication Date Title
MY147832A (en) Compounds for enzyme inhibition
CR20120451A (en) COMPOUNDS FOR INHIBITION OF IMMUNOPROTEASOMAS
EA201300860A1 (en) CRYSTALLINE TRIPEPTIDE EPOXYKETON-PROTEASE INHIBITORS
MX2011008289A (en) Tablets for combination therapy.
TN2011000293A1 (en) Protein kinase inhibitors
MX2011011735A (en) Compounds and methods for inhibition of renin, and indications therefor.
MX2009011210A (en) 7-nonsubstituted indole mcl-1 inhibitors.
TN2014000128A1 (en) 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
MX2012000709A (en) Pyrrolopyridine inhibitors of kinases.
MX2009011211A (en) 7-substituted indole mcl-1 inhibitors.
MX2009006706A (en) Bicyclic heterocyclic compounds as fgfr inhibitors.
MX2011009796A (en) Inhibitors of pi3 kinase.
MX2009005649A (en) Treatment for multiple myeloma.
TN2011000291A1 (en) Purine compounds
MX2009006542A (en) Inhibitors of histone deacetylase and prodrugs thereof.
GEP20125647B (en) Kinesin inhibitors as cancer therapeutics
AU2011326186A8 (en) Selective glycosidase inhibitors and uses thereof
EP1987838A4 (en) Novel compound for treatment of tumor
EP1864134A4 (en) Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity
MX2010006039A (en) Rna antagonist compounds for the modulation of pik3ca expression.
EP2254411A4 (en) Complement inhibitors as therapeutic agents for treatment of cancer
WO2007008502A3 (en) Inhibitors of checkpoint kinases
WO2007084135A3 (en) Inhibitors of checkpoint kinases
WO2007081572A3 (en) Inhibitors of checkpoint kinases
MX2009012079A (en) Condensed heterocyclic compounds as inhibitors of protein kinases.